Description
The abstract highlights a fundamental paradox: decreased Ih current increases neuronal excitability in electrophysiological experiments, yet blocking Ih in vivo can be antiepileptic. This contradiction suggests unknown compensatory mechanisms or network-level effects that could reveal new therapeutic targets.
Gap type: contradiction Source paper: The Impact of Altered HCN1 Expression on Brain Function and Its Relationship with Epileptogenesis. (2023, Curr Neuropharmacol, PMID:37366350)
Resolution criteria
Resolved when an evidence artifact resolves the paradox of why Ih current blockade shows antiepileptic effects in vivo despite increasing neuronal excitability in vitro, with one of: (1) network-level recordings (multi-electrode array or in vivo EEG in freely-moving animals) after Ih blocker administration (ZD7288 or ivabradine at 5-20 mg/kg) in chronic epilepsy models (kainic acid or pilocarpine), demonstrating that the antiepileptic effect correlates with specific network state changes (reduced hypersynchronous firing) rather than single-neuron excitability; (2) layer-specific recordings in cortical or hippocampal circuits, showing that Ih blockade differentially affects excitatory versus inhibitory neuron populations (>=30% difference in firing rate change), with inhibitory neurons showing net circuit stabilization despite excitatory neuron disinhibition; (3) computational modeling ( conductance-based neuron network model with Ih current) demonstrating that network homeostasis or homeostatic plasticity compensates for increased single-neuron excitability in vivo but not in isolated neurons, with model predictions validated by experiment (>=80% prediction accuracy).